Riskpilot← Back to searchSign inGet full accessGhadir Vård AB
ABActiveOrg 5590797295Lavegatan 35General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2024
SEK 1,2M
+114% vs 2023
EBITDA margin
31.7%
-8% vs 2023
Equity ratio
63.2%
Financial strength
Net profit 2024
SEK 313K
-11% vs 2023
| Revenue | SEK 1,2M | +114% |
| EBITDA | SEK 394K | -8% |
| Net profit | SEK 313K | -11% |
| Total assets | SEK 580K | +4% |
| Equity | SEK 366K | -2% |
| Employees | 0 | — |
Legal name
Ghadir Vård AB
Org number
5590797295
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 oktober 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva sjukvård och konsultverksamhet inom Hälso- och sjukvård, samt handel med värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Lavegatan 35
Email
muttar1982@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 45 | 38 | 22 | 582 | 1 243 |
| Staff expenses | — | — | — | −35 | −259 |
| EBITDA | −8 | — | −8 | 430 | 394 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −8 | 0 | −8 | 430 | 394 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −8 | 0 | −8 | 430 | 394 |
| Tax | −0 | −0 | — | −79 | −82 |
| Net profit | −8 | 0 | −8 | 351 | 313 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 31 | 33 | 24 | 560 | 580 |
| Equity | 30 | 31 | 23 | 374 | 366 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 | 2 | 1 | 186 | 214 |
| Total debt | 1 | 2 | 1 | 186 | 214 |
EBITDA margin
31.7%
This company
15.8%
Market median
+101% vs market
20202024
Equity ratio
63.2%
This company
38.2%
Market median
+65% vs market
20202024
Return on equity
85.4%
This company
18.4%
Market median
+364% vs market
20202024
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20202024
Asset turnover
2.14×
This company
1.12×
Market median
+91% vs market
20202024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ghadir Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Patrik Ådemark | Deputy Board Member | 0 companies |
| Mariam Samir Abdulrazzak Al-Sabbag | Board of Directors | 0 companies |
| Mohammed Adel Mohammed Awad | Deputy Board Member | 0 companies |
| Ali Farhan Muttar Muttar | Chairman | 0 companies |